89291-76-9

Basic information

• Product Name: (3aS,6aR)-6-(benzyloxyMethyl)-2,2-diMethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol
• Synonyms: (3aS,6aR)-6-(benzyloxyMethyl)-2,2-diMethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol
• CAS NO: 89291-76-9
• Molecular Formula: C₁₆H₂₀O₄
• Molecular Weight: 276.3276
• Mol File: 89291-76-9.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (3aS,6aR)-6-(benzyloxyMethyl)-2,2-diMethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (3aS,6aR)-6-(benzyloxyMethyl)-2,2-diMethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol(89291-76-9)
• EPA Substance Registry System: (3aS,6aR)-6-(benzyloxyMethyl)-2,2-diMethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol(89291-76-9)

Safety Data

• Hazardous Substances Data: 89291-76-9(Hazardous Substances Data)

Usage

General Description

(3aS,6aR)-6-(benzyloxymethyl)-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, also known as CDX-085, is a chemical compound that belongs to the class of cyclopentadioxol compounds. It is a white crystalline powder with a molecular formula of C15H20O4 and a molecular weight of 264.32 g/mol. CDX-085 is commonly used as a synthetic intermediate in the production of pharmaceuticals and agrochemicals. It is also used in the synthesis of other organic compounds and can be utilized in research and development applications in the chemical industry. Additionally, it may possess certain biological activities and pharmacological properties that make it a subject of interest in medicinal chemistry and drug discovery.

Upstream product

• 89291-72-5 C₃₂H₃₅O₁₀P 
• 117307-62-7 (3aR,6aR)-6-Benzyloxymethyl-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-one 
• 89291-75-8 (3aR*,6aR*)-6-Benzyloxymethyl-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-one 
• 89291-71-4 {2-[(4S,5R)-5-((R)-2-Benzyloxy-1-hydroxy-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-2-oxo-ethyl}-phosphonic acid dimethyl ester 
• 89291-74-7 {2-[(4S,5S)-5-(2-Benzyloxy-acetyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-2-oxo-ethyl}-phosphonic acid dimethyl ester 
• 117251-95-3 Dimethyl (6-O-benzyl-3,4-O-isopropylidene-α-D-ribo-2-hexulofuranosyl)phosphonate 
• 114933-42-5 Acetic acid (3aS,4S,6aS)-4-benzyloxymethyl-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-yl ester 
• 114948-34-4 (3aS,4S,6aS)-4-Benzyloxymethyl-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-ol 
• 104010-72-2 (3aS,6aS)-2,2-dimethyl-3a,6a-dihydro-4H-cyclopenta[d][1,3]dioxol-4-one 
• 66222-28-4 (benzyloxymethyl)tributylstannane 
• 85846-80-6 5-O-benzyl-2,3-O-isopropylidene-D-ribono-1,4-lactone 
• 85846-80-6 (-)-5-O-benzyl-2,3-O-isopropylidene-D-ribono-1,4-lactone 
• 117251-95-3 (-)-6-O-benzyl-1-deoxy-1-(dimethylphosphono)-3,4-O-isopropylidene-D-ribo-hexofuranose 
• 100-39-0 benzyl bromide 

Downstream Products

• 169191-14-4 (1S,4R,5S)-3-<(benzyloxy)methyl>-4-tert-butyloxy-5-hydroxy-2-cyclopenten-1-ol 
• 243462-61-5 (3aR,4S,6aR)-6-(Benzyloxymethyl)-4-(tert-butyldimethylsilyloxy)-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol 
• 459867-30-2 (1S,4R,5S)-1-benzyloxy-3-[(benzyloxy)methyl]-4,5-(isopropylidenedioxy)-2-cyclopentene 
• 290823-01-7 (1S,2S,3S,4S,5S)-(-)-4-(6-amino-purin-9-yl)-1-benzyloxymethyl-6-oxa-bicyclo[3.1.0]hexane-2,3-diol 
• 290823-00-6 (1R,2S,3S,4S,5R)-(-)-4-(6-amino-purin-9-yl)-1-benzyloxymethyl-6-oxa-bicyclo[3.1.0]hexane-2,3-diol 
• 290822-99-0 (1S,2S,3S,4S,5S)-(-)-1-benzyloxymethyl-4-(6-chloropurin-9-yl)-6-oxa-bicyclo[3.1.0]hexane-2,3-diol 
• 290822-98-9 (1R,2S,3S,4S,5R)-(-)-1-benzyloxymethyl-4-(6-chloropurin-9-yl)-6-oxa-bicyclo[3.1.0]hexane-2,3-diol 
• 290822-97-8 (-)-9-[(1R,4R,5S)-3-(benzyloxy)methyl-4,5-dihydroxycyclopent-2-en-1-yl]-6-chloropurine 
• 459867-38-0 (+)-9-[(1R,2R,5S)-5-benzyloxy-3-(benzyloxy)methyl-2-(methoxy)methoxy-cyclopent-3-en-1-yl]-6-chloropurine 
• 459867-40-4 (+)-9-[(1R,2R,5S)-5-benzyloxy-3-(benzyloxy)methyl-2-hydroxy-cyclopent-3-en-1-yl]-6-aminopurine 
• 459867-39-1 (+)-9-[(1R,2R,5S)-5-benzyloxy-3-(benzyloxy)methyl-2-hydroxy-cyclopent-3-en-1-yl]-6-chloropurine 
• 459867-37-9 (1S,4R,5S)-1,5-dibenzyloxy-3-[(benzyloxy)methyl]-4-[(methoxy)methoxy]-cyclopent-2-ene 
• 459867-33-5 (1S,4R,5S)-1,5-di(benzyloxy)-3-[(benzyloxy)methyl]cyclopent-2-en-4-ol 
• 459867-32-4 (1S,4R,5S)-1,4-di(benzyloxy)-3-[(benzyloxy)methyl]cyclopent-2-en-5-ol 

Relevant articles and documents

Design, synthesis, and biological evaluation of fluoroneplanocin A as the novel mechanism-based inhibitor of S-adenosylhomocysteine hydrolase

Fluoroneplanocin A (12) was designed as a novel mechanism-based inhibitor of S-adenosylhomocysteine hydrolase (SAH) and efficiently synthesized via an electrophilic vinyl fluorination reaction (n-BuLi, N-fluorobenzenesulfonimide at -78 °C). Fluoroneplanoc

Chiral pool synthesis of 4a-substituted carbocyclic cyclopentanoid nucleoside precursors, I

A suitable protected D-ribono-1,4-lactone derivative has been used for the straightforward chiral pool synthesis of cyclopentanoid nucleoside precursors. Thus, epoxidation followed by deoxygenation or regioselective ring opening led to nucleoside precurso

TOTAL SYNTHESIS OF (+/-)-NEPLANOCIN F

(+/-)-Neplanocin F was synthesized in 12 steps from the racemate (3/4), which was available from D-ribonolactone.